Trials / Withdrawn
WithdrawnNCT04510727
Optical Coherence Tomography Guided C&D
Using OCT Imaging to Determine the Presence of Residual Tumor Cells After C&D for Superficial and Nodular BCC: A Prospective Study.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to identify the presence of residual superficial and nodular basal cell carcinoma (BCC) status-post curettage and desiccation (C\&D) by using optical coherence tomography (OCT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Optical Coherence Tomography (OCT) | VivoSight Dx OCT system from Michelson Diagnostics Ltd. OCT will be used to visualize the tumor and lesion in the skin. |
| PROCEDURE | Curettage & Desiccation (C&D) Procedure | Standard of care C\&D where the basal cell carcinoma lesion will be scraped to its base using a Fox dermal curette and an electrodesiccation machine. |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2020-08-12
- Last updated
- 2024-02-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04510727. Inclusion in this directory is not an endorsement.